Recent Updates
Recently added Catalysts
IMRN Positive Sentiment

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Thursday, February 8, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Immuron Limited has announced that its CEO, Steven Lydeamore, will present at the Monsoon Communications Investor function in Sydney on February 8, 2024. This event is an opportunity to engage with investors and share company developments. Furthermore, the slide deck for the presentation will be accessible on the company's website, promoting transparency and communication. Immuron is focused on developing targeted polyclonal antibodies for infectious diseases.
Price reaction · baseline $1.79 (2024-02-07 close) · hit after-hours · 2 other IMRN headline(s) in the window, move may be shared
day 0 close
-1.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Steven Lydeamore will present at a notable investor function.
  • The presentation could enhance investor confidence in Immuron.
  • Availability of the presentation online increases transparency.

Full Press Release Details

MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore will be presenting at the Monsoon Communications Investor function on Thursday, 8th February in Sydney, Australia.
A copy of the presentation slide deck is available on the Company’s website.
https://www.immuron.com.au/corporate-presentations/
Authorized for release by the Board of Immuron Limited.
Chief Executive Officer
Ph: +61 (0)3 9824 5254
Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.
For more information visit: http://www.immuron.com

Frequently Asked Questions

When is the Immuron Limited presentation scheduled?

The presentation is on February 8, 2024.

Who is presenting at the Monsoon Communications event?

CEO Steven Lydeamore will be presenting.

Where can I find the presentation slides?

The slides are available on Immuron's website.

What is Immuron Limited's focus?

They develop orally delivered targeted polyclonal antibodies.

Which diseases does Immuron aim to treat?

Immuron targets infectious diseases for treatment.

ShareAdd on Google
Tags: IMRN Viatris Investor Conferences Healthcare Immuron Steven Lydeamore investor presentation biopharmaceuticals
Last updated: Feb 8, 2024

Biotech snapshot

Lead asset
TravelanPhase 2
Diarrhea →